Esperion Therapeutics (ESPR) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

ESPR Esperion Therapeutics

Watchlist

1.960
-0.010-0.51%

Close Aug 16 16:00 ET

1.980
+0.020+1.02%

Post 18:58 ET

384.60MMarket Cap-2305P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Esperion Therapeutics Is Maintained at Buy by Needham
Dow JonesAug 13 06:11 ET
Express News | Esperion Therapeutics Inc : Needham Cuts Target Price to $6 From $8
ReutersAug 13 01:15 ET
Q2 2024 Esperion Therapeutics Inc Earnings Call
Yahoo FinanceAug 13 01:06 ET
Earnings Call Summary | Esperion Therapeutics(ESPR.US) Q2 2024 Earnings Conference
moomoo AIAug 12 22:24 ET · Conference Call
Esperion Therapeutics, Inc. (ESPR) Q2 2024 Earnings Call Transcript
Earnings Call TranscriptsAug 12 21:50 ET
Esperion Therapeutics | 10-Q: Q2 2024 Earnings Report
SEC announcementAug 12 16:12 ET · Announcements

Comments

Arvosh

Aug 13 02:48

$Esperion Therapeutics (ESPR.US)$ earnings call came out promising, keen to see this baby rise! 🪽

Jaguar8

Aug 12 05:02

NEWS

$Esperion Therapeutics (ESPR.US)$
Esperion Reports Second Quarter 2024 Financial Results and Provides a Business Update
Positive
Total revenue increased 186% year-over-year to $73.8 million
U.S. net product revenue grew 39% to $28.3 million
Monetized European royalties for $304.7 million, enhancing financial flexibility
Expanded payer coverage, with over 80% updating utilization management criteria
Increased preferred commercial coverage to 92% and Medicare preferred coverage to over 50%
Rec...